LeafNLP Demos
Back to explore

Report #2875407

Received Nov 28, 2025

Office visit

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
19 yrs
State
WI
Recovered
Recovered
Vaccinated
Nov 28, 2025
Onset
Nov 28, 2025
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1—IM / RA
MENBMENINGOCOCCAL B (BEXSERO)NOVARTIS VACCINES AND DIAGNOSTICS1—IM / LA
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICS1—IM / LA

Symptoms (6)

Blindness transientDisorientationHyperhidrosisImmediate post-injection reactionPallorPresyncope

Symptom narrative

Patient presented with significant anxiety related to vaccine administration. After discussion with the medical assistant, the vaccine was administered. Immediately post-injection, the patient exhibited vasovagal symptoms, including diaphoresis, pallor, disorientation, and transient vision loss lasting approximately 3 minutes. Nursing assessment noted bilateral pupillary dilation. An attempt to obtain blood pressure was unsuccessful due to inability of the automated cuff to generate a reading. The patient was placed in a safe position and provided with oral fluids (water and juice) and crackers. Deep-breathing techniques were encouraged. Symptoms gradually resolved; pupillary size returned to baseline and the patient reported full restoration of vision without further complications.

Current illness

None

Medical history

None

Other medications

None

Allergies

NKA

Lab data

N/A